TRX Gold Corporation announced it will present updates on its Buckreef Mine expansion in Tanzania at Red Cloud's Fall Mining Showcase 2026, held in Toronto on October 28-29. The company is focused on increasing gold production and advancing its high-margin Buckreef Gold Project, which has strong resource estimates and a positive economic outlook from a 2025 study. This presentation offers investors insight into TRX Gold's growth plans and commitment to sustainable mining practices. The event provides a platform for TRX Gold to engage with shareholders and industry leaders.
TRX Gold's upcoming presentation at Red Cloud's Fall Mining Showcase 2026 is contextually set against the Basic Materials sector's market activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Oct 19, 2026 19:02 WIB: Out of 83 priced Basic Materials-sector US stocks, 37 rose and 35 fell today. Notable movers include Albemarle Corp. (ALB) at USD 96.99 with a 1-day change of +1.58%, Freeport-McMoRan Inc (FCX) at USD 68.51 down -1.48%, and Steel Dynamics Inc. (STLD) at USD 244.01 up +1.44%.
Nyxoah announced preliminary Q3 2026 revenue of €9.2 million, up 19% sequentially, driven by a 29% increase in U.S. sales. The company submitted a PMA supplement to the FDA to expand its Genio device indication for patients with complete concentric c...
ASML Holding N.V. announced recent transactions under its ongoing share buyback program, repurchasing a total of 233,867 shares between October 12 and October 16, 2026. The shares were bought back at weighted average prices ranging from €1,444.83 to ...
The Phase 3 ALKIVIA trial demonstrated that efgartigimod significantly improves symptoms in patients with autoimmune myositis, including immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM). Patients showed meaningful clinical improve...
In 2025, Berkshire Hathaway, led by Greg Abel, received $479 million in dividends from its $1.3 billion investment in American Express. This highlights the value of holding strong dividend-paying stocks for steady income. Retail investors can apply s...
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
